These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8657542)

  • 1. Efficacy of low-dose dextromethorphan in the treatment of nonketotic hyperglycinemia.
    Alemzadeh R; Gammeltoft K; Matteson K
    Pediatrics; 1996 Jun; 97(6 Pt 1):924-6. PubMed ID: 8657542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia.
    Zammarchi E; Donati MA; Ciani F; Pasquini E; Pela I; Fiorini P
    Neuropediatrics; 1994 Oct; 25(5):274-6. PubMed ID: 7885541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early myoclonic encephalopathy and nonketotic hyperglycinemia.
    Rossi S; Daniele I; Bastrenta P; Mastrangelo M; Lista G
    Pediatr Neurol; 2009 Nov; 41(5):371-4. PubMed ID: 19818941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant.
    Hamosh A; McDonald JW; Valle D; Francomano CA; Niedermeyer E; Johnston MV
    J Pediatr; 1992 Jul; 121(1):131-5. PubMed ID: 1385627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia.
    Hamosh A; Maher JF; Bellus GA; Rasmussen SA; Johnston MV
    J Pediatr; 1998 Apr; 132(4):709-13. PubMed ID: 9580775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical increase in seizure frequency with valproate in nonketotic hyperglycinemia.
    Tsuyusaki Y; Shimbo H; Wada T; Iai M; Tsuji M; Yamashita S; Aida N; Kure S; Osaka H
    Brain Dev; 2012 Jan; 34(1):72-5. PubMed ID: 21316884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor.
    Schmitt B; Steinmann B; Gitzelmann R; Thun-Hohenstein L; Mascher H; Dumermuth G
    Neurology; 1993 Feb; 43(2):421-4. PubMed ID: 8437713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical progress of neonatal non-ketotic hyperglycinemia under treatment].
    García-Pérez A; Martínez-Granero MA; Martín-Ancel AM; Bonet-Serra B; García-Muñoz MJ; García-Segura JM; Viaño J; Lama-More RA
    Rev Neurol; 2004 Oct 16-31; 39(8):727-30. PubMed ID: 15514900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-frequency rhythmic cortical myoclonus in a long-surviving patient with nonketotic hypergylcemia.
    Mastrangelo M; Canafoglia L; Franceschetti S; Oppezzo C; Mosca F; Menni F; Parini R; Ciano C; Scaioli V; Panzica F
    J Child Neurol; 2008 Mar; 23(3):321-4. PubMed ID: 18182648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist.
    Tortella FC; Britton P; Williams A; Lu XC; Newman AH
    J Pharmacol Exp Ther; 1999 Oct; 291(1):399-408. PubMed ID: 10490930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonketotic hyperglycinemia: treatment with diazepam--a competitor for glycine receptors.
    Matalon R; Naidu S; Hughes JR; Michals K
    Pediatrics; 1983 Apr; 71(4):581-4. PubMed ID: 6300746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonketotic hyperglycinemia: biochemical, molecular, and neurological aspects.
    Kure S; Tada K; Narisawa K
    Jpn J Hum Genet; 1997 Mar; 42(1):13-22. PubMed ID: 9183995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonketotic hyperglycinemia in a newborn infant.
    Tekinalp G; Coşkun T; Oran O; Ozalp I; Figen G; Ergin H
    Turk J Pediatr; 1995; 37(1):57-60. PubMed ID: 7732609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of strychnine treatment during the neonatal period in three Finnish children with nonketotic hyperglycinemia.
    von Wendt L; Similä S; Saukkonen AL; Koivisto M
    Pediatrics; 1980 Jun; 65(6):1166-9. PubMed ID: 7375243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonketotic hyperglycinemia. Glycine accumulation due to absence of glycerine cleavage in brain.
    Perry TL; Urquhart N; MacLean J; Evans ME; Hansen S; Davidson GF; Applegarth DA; MacLeod PJ; Lock JE
    N Engl J Med; 1975 Jun; 292(24):1269-73. PubMed ID: 1128590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycine encephalopathy.
    Dalla Bernardina B; Aicardi J; Goutières F; Plouin P
    Neuropadiatrie; 1979 Aug; 10(3):209-25. PubMed ID: 583064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient neonatal nonketotic hyperglycinemia: a 13-year follow-up.
    Zammarchi E; Donati MA; Ciani F
    Neuropediatrics; 1995 Dec; 26(6):328-30. PubMed ID: 8719751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neonatal form of a nonketotic hyperglycinemia in consanguinous parents].
    Plöchl E; Rittinger O; Doringer E; Laubichler W
    Klin Padiatr; 1991; 203(6):455-7. PubMed ID: 1758150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-ketotic hyperglycinemia].
    Kálmánchey R; Szücs L; Majtényi K; Liptai Z; Dobos M; Krause I; Nagy I
    Orv Hetil; 1995 Jan; 136(5):245-9. PubMed ID: 7772127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of tryptophan for the treatment of nonketotic hyperglycinemia: a new therapeutic approach for modulating the N-methyl-D-aspartate receptor.
    Matsuo S; Inoue F; Takeuchi Y; Yoshioka H; Kinugasa A; Sawada T
    Pediatrics; 1995 Jan; 95(1):142-6. PubMed ID: 7770295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.